16 What part will artificial intelligence and machine learning play in risk assessment that will expedite patient diagnosis and treatment? What Does the Future Hold? Much is now known about Lp(a) and its role in CVD. But more evidence is needed to inform future recommendations for clinical practice. For Lp(a) to be accepted as a risk factor for intervention, randomized outcome trials of specific Lp(a) lowering that demonstrate reduction in CVD risk are required. The results of these trials will provide the initial answers as to the benefits of Lp(a) lowering but many important unanswered questions are likely to remain, requiring further investigation.
RkJQdWJsaXNoZXIy MjI2NjI=